SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

DXCM

DexCom, Inc.
NASDAQHealth Care

Latest close: 86.04 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Notice of sale · Form 144MICHAEL BROWN · Officer · $145.3KOpen the filing ↗
  2. Sep 28, 2026Reported sale · Form 4Sadie Stern, EVP Chief People & Culture Off · $221.0KOpen the filing ↗
  3. Sep 28, 2026Notice of sale · Form 144SADIE STERN · Officer · $221.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record2,50010 flagged findings
Reported transactions (Form 4)40since May 22, 2026 · and 1 other holding
Corporate events (8-K)30since Sep 13, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-07-30share offering or dilution eventfreshOpen filing ↗
    “…273.7 278.7 Total assets $ 6,455.3 $ 6,339.9 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable and…”
    +1 more passage from the same document
    • “…fair value hierarchy: Fair Value Measurements Using (In millions) Level 1 Level 2 Level 3 Total Cash equivalents $ 409.0 $ — $ — $…”
  • 2026-07-30capital return (buybacks/dividends)freshOpen filing ↗
    “…9.7 13.5 21.3 26.3 Selling, general and administrative 26.2 27.8 55.1 46.0 Total share-based compensation expense $ 39.0 $…”
    +1 more passage from the same document
    • “…administrative 26.2 27.8 55.1 46.0 Total share-based compensation expense $ 39.0 $ 45.3 $ 82.3 $ 79.5 As of June 30, 2026,…”
  • 2026-05-15capital return (buybacks/dividends)recentOpen filing ↗
    “…and Adjusted EBITDA Margin is not available without unreasonable effort. The definitions of the non-GAAP financial metrics…”
    +1 more passage from the same document
    • “…Report on Form 8-K filed on February 12, 2026. ITEM 8.01. OTHER EVENTS. On May 14, 2026, Dexcom announced that its Board of…”
  • 2026-04-30share offering or dilution eventrecentOpen filing ↗
    “…285.9 278.7 Total assets $ 6,633.3 $ 6,339.9 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable and…”
    +1 more passage from the same document
    • “…Fair Value Measurements Using (In millions) Level 1 Level 2 Level 3 Total Cash equivalents $ 524.4 $ 13.8 $ — $ 538.2 Debt…”
  • 2026-04-30capital return (buybacks/dividends)recentOpen filing ↗
    “…sales $ 2.8 $ 3.2 Research and development 11.6 12.8 Selling, general and administrative 28.9 18.2 Total share-based compensation…”
    +1 more passage from the same document
    • “…compensation expense $ 43.3 $ 34.2 As of March 31, 2026, unrecognized estimated compensation costs related to RSUs and PSUs…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 2,500)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

2,500 filings on record, the oldest from Apr 13, 05.

Listing the 25 most recent filings of the 2,500 on record.

8-Ks, explained

Stress1Structure78Governance78
  • Governance12 senior executive changes2025 – 2026show all 12hide
    • Sep 14, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 10, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Mar 2, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 26, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Dec 22, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Oct 27, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Sep 16, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 30, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 13, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • May 9, 25GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • May 9, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • May 2, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 25, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Mar 10, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Dec 23, 24StructureEntered a material agreement8-K 1.01 ↗
  • Feb 15, 24StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Aug 28, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 19, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 5, 23StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2021 – 2022show all 3hide
    • Aug 31, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jul 8, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Dec 17, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 14, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Sep 14, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 13, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗

The record reaches back to May 18, 05.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Feb 21, 19StressRestructuring plan with committed costs+1 more in the same filing8-K 2.05 ↗

The full record holds 1 stress filing.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 15, MICHAEL BROWN filed notice of intent to sell up to $145K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+9 more recent notices · 9 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 28, 26Sell$221KSadie SternEVP Chief People & Culture Off↗
  • Sep 15, 26Sell$143KMichael Jon BrownEVP Chief Legal Compliance Off↗
  • Sep 15, 26Sell$550KNICHOLAS AUGUSTINOS↗
  • Sep 14, 26Sell$130KNICHOLAS AUGUSTINOS↗
  • Sep 10, 26Sell$303KJereme M SylvainEVP, Chief Financal Officer↗
  • Aug 27, 26Sell$227KSadie SternEVP Chief People & Culture Off↗
  • Aug 20, 26Sell$1.7MKEVIN R SAYERExecutive Chair↗
  • Aug 20, 26Sell$667KKEVIN R SAYERExecutive Chair↗
  • Aug 20, 26Sell$9KKEVIN R SAYERExecutive Chair↗
  • Aug 14, 26Sell$156KMichael Jon BrownEVP Chief Legal Compliance Off↗
  • Aug 12, 26Sell$89KBridgette P Heller↗
  • Aug 3, 26Sell$171KMARK G FOLETTA↗

There are 9 more transactions in this stretch.

Stock compensation, tax and giftsshow the 19 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 10, 26Compensationamount n/aGlenn S Boehnlein↗
  • Aug 22, 26Tax$134KSadie SternEVP Chief People & Culture Off↗
  • Aug 22, 26Tax$134KMichael Jon BrownEVP Chief Legal Compliance Off↗
  • Aug 22, 26Tax$134KJereme M SylvainEVP, Chief Financal Officer↗
  • Aug 22, 26Tax$134KJacob Steven LeachPresident, CEO, and Director↗
  • Aug 12, 26Giftamount n/aNICHOLAS AUGUSTINOS↗
  • May 28, 26Compensationamount n/aRENEE D GALA↗
  • May 28, 26Compensationamount n/aRichard Alexander Collins↗
  • May 28, 26Compensationamount n/aEuan A. Ashley↗
  • May 28, 26Compensationamount n/aRimma Driscoll↗
  • May 28, 26Compensationamount n/aAlbert Frederick Osterloh IV↗
  • May 28, 26Compensationamount n/aBridgette P Heller↗
  • May 28, 26Compensationamount n/aMARK G FOLETTA↗
  • May 28, 26Compensationamount n/aNICHOLAS AUGUSTINOS↗
  • May 28, 26Compensationamount n/aKyle Malady↗
  • May 28, 26Compensationamount n/aSTEVEN R ALTMAN↗
  • May 22, 26Tax$529KJon ColemanEVP, Chief Commercial Officer↗
  • May 22, 26Tax$104KSadie SternEVP Chief People & Culture Off↗
  • May 22, 26Tax$104KJereme M SylvainEVP, Chief Financal Officer↗

The full record holds 388 transactions and goes back to Aug 11, 22.

Its sector and its market

DexCom, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From DexCom, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow DexCom, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
2,500 documents on file, from Apr 13, 2005 to Oct 15, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.